Sanki Aditya K, Boucau Julie, Ronning Donald R, Sucheck Steven J
Department of Chemistry, The University of Toledo, Toledo, OH 43606, USA.
Glycoconj J. 2009 Jul;26(5):589-96. doi: 10.1007/s10719-008-9211-z. Epub 2008 Dec 4.
Antigen 85 (ag85) is a complex of acyltransferases (ag85A-C) known to play a role in the mycolation of the D-arabino-D-galactan (AG) component of the mycobacterial cell wall. In order to better understand the chemistry and substrate specificity of ag85, a trehalose monomycolate mimic p-nitrophenyl 6-O-octanoyl-beta-D-glucopyranoside (1) containing an octanoyl moiety in lieu of a mycolyl moiety was synthesized as an acyl donor. Arabinofuranoside acceptors, methyl alpha-D-arabinofuranoside (2), methyl beta-D-arabinofuranoside (3), and methyl 2-O-beta-D-arabinofuranosyl-alpha-D-arabinofuranoside (9) were synthesized to mimic the terminal saccharides found on the AG. The acyl transfer reaction between acyl donor 1 and acceptors 2, 3, and 9 in the presence of ag85C from Mycobacterium tuberculosis (M. tuberculosis) resulted in the formation of esters, methyl 2, 5-di-O-octanoyl-alpha-D-arabinofuranoside (10), methyl 5-O-octanoyl-beta-D-arabinofuranoside (11), and methyl 2-O-(5-O-octanoyl-beta-D-arabinofuranosyl)-5-O-octanoyl-alpha-D-arabinofuranoside (12) in 2 h, 2 h and 8 h, respectively. The initial velocities of the reactions were determined with a newly developed assay for acyltransferases. As expected, the regioselectivity corresponds to mycolylation patterns found at the terminus of the AG in M. tuberculosis. The study shows that D-arabinose-based derivatives are capable of acting as substrates for ag85C-mediated acyl-transfer and the acyl glycoside 1 can be used in lieu of TMM extracted from bacteria to study ag85-mediated acyl-transfer and inhibition leading to the better understanding of the ag85 protein class.
抗原85(Ag85)是一种酰基转移酶复合物(Ag85A - C),已知其在分枝杆菌细胞壁的D - 阿拉伯糖 - D - 半乳聚糖(AG)成分的霉菌酸酯化过程中发挥作用。为了更好地理解Ag85的化学性质和底物特异性,合成了一种海藻糖单霉菌酸酯类似物对硝基苯基6 - O - 辛酰基 - β - D - 吡喃葡萄糖苷(1),其含有辛酰基部分以替代霉菌酰基部分作为酰基供体。合成了阿拉伯呋喃糖苷受体,α - D - 阿拉伯呋喃糖苷甲酯(2)、β - D - 阿拉伯呋喃糖苷甲酯(3)和2 - O - β - D - 阿拉伯呋喃糖基 - α - D - 阿拉伯呋喃糖苷甲酯(9),以模拟在AG上发现的末端糖类。在来自结核分枝杆菌(M. tuberculosis)的Ag85C存在下,酰基供体1与受体2、3和9之间的酰基转移反应分别在2小时、2小时和8小时内导致酯类物质2, 5 - 二 - O - 辛酰基 - α - D - 阿拉伯呋喃糖苷甲酯(10)、5 - O - 辛酰基 - β - D - 阿拉伯呋喃糖苷甲酯(11)和2 - O - (5 - O - 辛酰基 - β - D - 阿拉伯呋喃糖基) - 5 - O - 辛酰基 - α - D - 阿拉伯呋喃糖苷甲酯(12)的形成。反应的初始速度通过新开发的酰基转移酶测定法来确定。正如预期的那样,区域选择性与在结核分枝杆菌AG末端发现的霉菌酸酯化模式相对应。该研究表明,基于D - 阿拉伯糖的衍生物能够作为Ag85C介导的酰基转移的底物,并且酰基糖苷1可以替代从细菌中提取的海藻糖单霉菌酸酯来研究Ag85介导的酰基转移和抑制作用,从而更好地理解Ag85蛋白类别。